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Abstract
Background: Obesity is a common disorder with a negative impact on IVF treatment outcome.
It is not clear whether morbidly obese women (BMI >= 35 kg/m2) respond to treatment differently
as compared to obese women (BMI = 30–34.9 kg/m2) in IVF. Our aim was to compare the outcome
of IVF or ICSI treatments in obese patients to that in morbidly obese patients.
Methods: This retrospective cohort study was conducted in a tertiary care centre. Patients
inclusion criteria were as follows; BMI ≥ 30, age 20–40 years old, first cycle IVF/ICSI treatment with
primary infertility and long follicular pituitary down regulation protocol.
Results: A total of 406 obese patients (group A) and 141 morbidly obese patients (group B)
satisfied the inclusion criteria. Average BMI was 32.1 ± 1.38 kg/m2 for group A versus 37.7 ± 2.99
kg/m2 for group B. Patient age, cause of infertility, duration of stimulation, fertilization rate, and
number of transferred embryos were similar in both groups. Compared to group A, group B had
fewer medium size and mature follicles (14 vs. 16), fewer oocytes collected (7 vs. 9) and required
higher doses of HMG (46.2 vs. 38.5 amps). There was also a higher cancellation rate in group B
(28.3% vs. 19%) and lower clinical pregnancy rate per started cycle (19.9% vs. 28.6%).
Conclusion: In a homogenous infertile and obese patient population stratified according to their
BMI, morbid obesity is associated with unfavorable IVF/ICSI cycle outcome as evidenced by lower
pregnancy rates. It is recommended that morbidly obese patients undergo appropriate counseling
before the initiation of this expensive and invasive therapy.
Background
Obesity is considered to be the greatest nutritional prob-
lem in the industrialized world [1,2]. The World Health
Organization (WHO) and the National Institutes of
Health (NIH) define obesity as the body mass index
(BMI) of ≥ 30 kg/m2. Obesity is further divided into three
categories; class I obesity with BMI = 30–34.9 kg/m2, class
II with BMI = 35–39.9 kg/m2, and class III with BMI ≥ 40
kg/m2 [1,2]. This classification corresponds to increasing
health risks of the obesity related comorbidities.
In Saudi females at childbearing age, obesity is among the
most frequently encountered multifactorial disorders and
it has been reported that 38% of females attending a refer-
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ral in vitro fertilization (IVF) program suffers from obesity
[3,4].
Multiple reproductive dysfunctions have been associated
with obesity including anovulation, and infertility [5].
Obese patients undergoing IVF or intracytoplasmic sperm
injection (ICSI) treatment are known to have increased
FSH requirement, fewer collected oocytes, and frequent
cycle cancellation, lower pregnancy rate and increase mis-
carriage rate than their non-obese counterpart [6-15].
In the literature, it is unclear whether response and out-
come of women who are morbidly obese (class II and III
obesity; BMI ≥ 35 kg/m2) differ from their class I (BMI 30–
34.9) counterparts in IVF or ICSI treatment cycle.
The objective of this study is to compare the outcome of




Patients who were 20–40 years old, had no living chil-
dren, and underwent their first cycle of IVF/ICSI treatment
with long follicular pituitary down regulation protocol
followed by controlled ovarian stimulation at King Faisal
Specialist Hospital and Research Centre, Riyadh, Saudi
Arabia between January 2000 to December 2003 were
included in this retrospective cohort study.
Ovarian stimulation, oocyte retrieval, semen preparation,
embryo culture, and embryo transfer protocols have been
performed as previously published [16]. Briefly, pituitary
suppression was achieved by gonadotrophin-releasing
hormone agonist long protocol by IM. injection of 1.875
mg Lupron Depot (Abbott Laboratories, Chicago, Illinois,
USA) on day 3 of the menstrual cycle. Twenty-one days
after the Lupron injection, ovarian stimulation was initi-
ated with 225 IU (3 ampoules) daily IM. injection of
human menopausal gonadotrophin (Menegon; Ferring,
Germany) and adjusted according to patients' response.
Ten thousand IU of human chorionic gonadotrophin
(HCG) (Pregnyl, Organon, Oss, the Netherlands) were
given IM. When three or more follicles reached 18 mm in
diameter, oocyte retrieval was performed with transvagi-
nal ultrasound guidance under IV sedation 36 h after
HCG injection. The follicular aspirate was poured into 60
mm Falcon dishes (Beckton Dickinson Labware, Franklin
Lakes, New Jersey, USA) and cumulus-oocyte complexes
were transferred into another dish with Medi-Cult flush
medium (Medi-Cult, Jillinge, Denmark). Each complex
was evaluated for maturity based on cumulus-corona cell
morphology. Cumulus-oocyte complexes were trans-
ferred into IVF medium (Medi-Cult). Fertilization was
achieved by IVF or ICSI. On day 3, the two best by mor-
phology dividing embryos (if available) were transferred
under ultrasound guidance. Patients were supplemented
with progesterone (100 mg/daily IM, Steris Laboratories
Inc., Phoenix, Arizona, USA). Pregnancy was first con-
firmed with a Tandom Icon urine HCG test (Hybritech,
San Diego, California, USA) and serum βHCG concentra-
tions at 13 days, and by ultrasound 5 weeks after embryo
transfer. The pregnancies reported in this study are clinical
pregnancies where fetal heart beat was positive by trans-
vaginal ultrasound scan at 7th gestational week, so all bio-
chemical pregnancies (when a previously positive
pregnancy test became negative before ultrasonographic
detection of an embryonic sac in the fifth week of preg-
nancy or later), and preclinical losses (if the loss occurred
after the gestational sac is seen but before the fetal heart
activity is seen) were excluded.
Statistics
Patients were divided into two groups: group (A) included
obese women with BMI 30–34.9 kg/m2; group (B)
included morbidly obese women with BMI ≥ 35 kg/m2.
Clinical pregnancy per started cycle was used as the pri-
mary outcome. Secondary outcomes included duration of
stimulation, cycle cancellation, number of oocyte
retrieved, and fertilization rate.
Statistical analysis was performed using S-plus 2000. A
two-tailed t-test was used for parametric data, a Mann-
Whitney test for non-parametric data, and Chi-square test
for binomial data. P < 0.05 was considered statistically sig-
nificant.
Results
During the study period, 1545 women aged 20–40 years
old had their first stimulation cycle using long follicular
pituitary down regulation protocol. In this population,
547 women (35%) had a BMI ≥ 30 kg/m2. Of those 406
women were obese, and 141 women were morbidly
obese. Average BMI in the obese patients was 32.1 ± 1.38
kg/m2, and 37.7 ± 2.99 kg/m2 for the morbidly obese ones
(p < 0.0001). Obese and morbidly obese women had sim-
ilar age, 30.6 ± 4.57 vs. 31.6 ± 5.1 years, respectively. Both
groups had similar primary causes of infertility (Table 1).
Table 2 shows the comparison of treatment outcome
between the two groups. Duration of stimulation was sim-
ilar in both groups, but the morbidly obese women
required much higher doses of HMG for stimulation.
Morbidly obese women also had a lower number of
medium size (between 11–17 mm) and mature follicles
(≥ 18 mm). In addition there was a higher cancellation
rate per started cycle for the morbidly obese women
(28.3% vs. 19%; P = 0.02). The cycle cancellation was
either due to poor ovarian response to gonadotropin stim-
ulation (less than 3 mature follicles) or increased risk ofReproductive Biology and Endocrinology 2009, 7:52 http://www.rbej.com/content/7/1/52
Page 3 of 5
(page number not for citation purposes)
ovarian hyperstimulation syndrome. The rate of sever
hyperstimulation syndrome was less than 1% in both
groups.
In this study, the number of patients who reached embryo
transfer or had more than one embryo to be selected for
transfer were higher in obese patients compared to those
who were morbidly obese (74% vs 62% with P = 0.025).
When compared to obese patients, morbidly obese
women also had lower clinical pregnancy rate per started
cycle (19.9% vs. 28.6%; p = 0.042).
The negative impact of obesity in the outcome of assisted
reproductive technology has been suggested by multiple
reports [6-15]. In these previous reports, the comparison
was made to the outcome achieved in women with nor-
mal body mass index. In this study, we report the outcome
of ART treatment for morbidly obese patients and com-
pared the outcome to their obese counterpart. The study
population was relatively homogenous, with comparable
age and cause of infertility. The treatment protocol was
standardized and all women were undergoing their first
treatment cycle. Our results suggest that morbidly obese
women have a lower pregnancy rate per started cycle when
compared to obese patients. This could be explained by
the fact that these women would have lower number of
medium size and mature follicles, and also had lower
number of oocyte retrieved, giving less choice in the selec-
tion of best embryos for transfer based on morphological
criteria.
While this study was not designed to study the mecha-
nism of the less favorable outcome in morbidly obese
population, data from Butzow et al. [17] and Gurbuz et al
[18] showing a positive correlation between BMI and the
leptin serum level during ovarian stimulation in IVF
cycles, and a negative correlation between increased levels
of leptin and the number of oocyte retrieved, suggests that
the main source of leptin is the adipose tissue. It is possi-
ble that high leptin concentration acting at the ovarian
level suppresses the ovarian response to gonadotropins.
These findings are consistent with our findings since the
morbidly obese women had a lower number of oocyte
retrieved. The insulin resistance, hyperinsulinemia, and
hyper androgeniemia increased with increasing BMI [5].
These hormonal changes might affect the ovarian
response, oocyte quality, embryo quality and/or endome-
trial receptivity as previously suggested [13,14,19,20]. In
this study, the lack of ovarian response and availability of
good quality embryos for transfer was the predisposing
factor for the lower pregnancy rate seen in morbidly obese
population.
Table 1: Patients' characteristics.
Group A (n = 406) Group B (n = 141) P value
Age (years) 30.6 ± 4.57 31.6 ± 5.1 NS
BMI (kg/m2) 32.1 ± 1.38 37.7 ± 2.99 <0.0001
Male factor (%) 265 (65.3%) 84 (59.6%) NS
Unexplained infertility (%) 45 (11.1%) 19 (13.5%) NS
Tubal Factor (%) 86 (21.2%) 32 (22.7%) NS
Ovulatory cycle 211 (52%) 63 (45%) NS
ICSI (%) 330 (81.3%) 118 (83.7%) NS
Note: Data are presented as mean ± SD unless other wise indicated, NS: P value is > 0.05.
Table 2: Comparison of cycle's outcome between obese and morbid obese patients.
Cycle outcome Group A (n = 406) Group B (n = 141) P value
Number of follicles 16 (9–22) 14 (7.5–19.5) 0.046
Number of oocyte collected 9 (4–14) 7 (3–13) 0.027
Number of fertilized oocytes 5 (2–8) 4 (1–7) NS
Number of embryos transferred:
1 30 (9%) 14 (14%) NS
2 299 (91%) 88 (86%) NS
Length of stimulation 14 (12–15) 14 (12–16) NS
Dose of HMG 36 (30–45) 44 (36–56) 0.047
Cancellation rate n (%) 77(19%) 40(28.3%) 0.02
Clinical Pregnancy rate n (%) 116(28.6%) 28(19.9%) 0.042
Preclinical loss 18 (4.4%) 8 (5.7%) NS
Biochemical pregnancy 8 (2%) 4 (2.8%) NS
Note: Data are presented as median (lower and upper quartile) unless other wise indicated.Reproductive Biology and Endocrinology 2009, 7:52 http://www.rbej.com/content/7/1/52
Page 4 of 5
(page number not for citation purposes)
A limitation of this study is that the live birth rate could
not be assessed due to our inability to complete follow up
with these patients after 7 weeks of gestation; most of
these patients receive care for their pregnancy in remote
areas. Additionally it would be interesting to know the
live birth rate per started cycle and the late miscarriage rate
(following +ve fetal heart beat) for the morbidly obese
population in comparison to the obese patients.
This is the largest published dataset describing the out-
come of morbidly obese women undergoing IVF/ICSI
treatment using the obese population as the control. One
of the important findings of this study was that the prob-
ability of cancellation per started cycle in morbidly obese
patients due to risk of ovarian hyperstimulation syn-
drome (OHSS), or due to lack of ovarian response was
higher than the probability of clinical pregnancy.
As other authors have suggested, weight loss might
improve the reproductive function of the obese popula-
tion [5,21-24]. We suggest that life style modification and
weight loss programs should be advised for the morbidly
obese women before they attempt IVF/ICSI treatment.
This in concordance with new recommendations of the
British Fertility Society recommendations to defer treat-
ment in obese women until a BMI of <35 is reached [25].
Summary
In a homogeneous infertile and obese population strati-
fied according to their BMI, morbidly obese women
undergoing IVF or ICSI therapy have lower clinical preg-
nancy rate when compare to obese patients. We would
suggest that before initiation of this expensive and inva-
sive therapy in morbidly obese population, couples
should receive counseling about the expected perform-
ance and the anticipated clinical pregnancy rate per
started cycle.
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